Structure-function studies of new C-20 epimer pairs of vitamin D3 analogs

European Journal of Biochemistry

Volumn 261, Issue 3, 1999, Pages 706-713

  Väisänen, Sami ^b   Ryhänen, Sanna ^b   Saarela, Janne T A ^b   Mäenpää, Pekka H ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b NONE

Author keywords

Analog; Calcitriol; Conformation; Transactivation; Vitamin D receptor

Indexed keywords

CALCITRIOL; CALCITRIOL DERIVATIVE; COLECALCIFEROL DERIVATIVE; LEXACALCITOL; MESSENGER RNA; OSTEOCALCIN; SEOCALCITOL; VITAMIN D RECEPTOR;

ARTICLE; BINDING AFFINITY; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; GENE EXPRESSION; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR MODEL; NORTHERN BLOTTING; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RADIOIMMUNOASSAY; STRUCTURE ACTIVITY RELATION; TRANSACTIVATION;

CHOLECALCIFEROL; HUMANS; MOLECULAR STRUCTURE; OSTEOCALCIN; PROTEIN BIOSYNTHESIS; RECEPTORS, CALCITRIOL; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0002874453     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1999.00318.x     Document Type: Article

References (26)

1. 1. Haussler, M.R., Whitfield, G.K., Haussler, C.A., Hsieh, J.-C., Thompson, P.D., Selznick, S.H., Dominguez, C.E. & Jurutka, P.W. (1998) The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J. Bone Miner. Res. 13, 325-349.
2. 2. Bouillon, R., Okamura, W.H. & Norman, A.W. (1995) Structure-function relationships in the vitamin D endocrine system. Endocr. Rev. 16, 200-257.
3. 3 receptor-like macromolecule in rat osteogenic sarcoma cell lines. J. Biol. Chem. 255, 4414-4417.
4. 3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells. J. Biol. Chem. 255, 11660-11663.
5. 3. Proc. Natl Acad. Sci. USA 86, 4455-4459.
6. 3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line. J. Cell Phys. 123, 401-409.
7. 3 on its receptor mRNA levels and osteocalcin synthesis in human osteosarcoma cells. Biochim. Biophys. Acta 1048, 30-37.
8. 8. Ryhänen, S., Mahonen, A., Jääskeläinen, T. & Mäenpää, P.H. (1996) Synthetic 20-epi analogs of calcitriol are potent inducers of target-gene activation in osteoblastic cells. Eur. J. Biochem. 238, 97-103.
9. 9. Väisänen, S., Juntunen, K., Itkonen, A., Vihko, P. & Mäenpää, P.H. (1997) Conformational studies of human vitamin-D receptor by antipeptide antibodies, partial proteolytic digestion and ligand binding. Eur. J. Biochem. 248, 156-162.
10. 3 and analog KH1060. Proc. Natl Acad. Sci. USA 93, 10685-10690.
11. 3 are associated with enhanced activation of the vitamin D receptor. J. Biol. Chem. 270, 10551-10558.
12. 12. Chomczynski, P. & Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiosyanate-phenol-cloroform extraction. Anal. Biochem. 162, 156-159.
13. 13. Celeste, A.J., Rosen, V., Buecker, J.L., Kriz, R., Wang, E.A. & Wozney, J.M. (1986) Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones. EMBO J. 5, 1885-1890.
14. 14. Brooks, B.R., Bruccoleri, R.E., Olason, B.D., States, D.J., Swaminathan, S. & Karplus, M. (1983) CHARHM: a program for macromolecular energy, minimization, and dynamics calculations. J. Comp. Chem. 4, 187-217.
15. 3 analog with an extensively modified side chain (CB1093). J. Cell. Bioch. 70, 414-424.
16. 3 analogues and their 20-epi homologues with the vitamin D receptor. J. Biol. Chem. 272, 3336-3345.
17. 3 receptor are important for the binding of calcitriol. FEBS Lett 440, 203-207.
18. 3. Mol. Endocrinol. 9, 1814-1824.
19. 3 correlates well with gene activation. J. Cell Biochem. 62, 325-333.
20. 20. Renaud, J.-P., Rochel, N., Ruff, M., Vivat, V., Chambon, P., Gronemeyer, H. & Moras, D. (1995) Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378, 681-689.
21. 21. Wagner, R.L., Apriletti, J.W., McGrath, M.E., West, B.L., Baxter, J.D. & Fletterick, R.J. (1995) A structural role for hormone in the thyroid hormone receptor. Nature 378, 690-697.
22. 22. Wurtz, J.-M., Bourguet, W., Renaud, J.-P., Vivat, V., Chambon, P., Moras, D. & Gronemeyer, H. (1996) A canonical structure for the ligand-binding domain of nuclear receptors. Nat. Struct. Biol. 3, 87-94.
23. 23. Brzozowski, A.M., Pike, A.C.W., Dauter, Z., Hubbard, R.E., Bonn, T., Engström, O., Öhman, L., Greene, G.L., Gustafsson, J.-Å & Carlquist, M. (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389, 753-758.
24. 24. Haussler, M.R., Jurutka, P.W., Hsieh, J.-C., Thompson, P.D., Selznick, S.H., Haussler, C.A. & Whitfield, G.K. (1995) New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Bone 17, 33S-38S.
25. 3 is due to reduced catabolism and altered protein binding. Biochem. Pharmacol. 47, 987-993.
26. 26. Dilworth, F.J., Williams, G.R., Kissmeyer, A.M., Nielsen, J.L., Binderup, E., Calverley, M.J., Makin, H.L. & Jones, G. (1997) The vitamin D analog, KH1060, is rapidly degraded both in vivo and in vitro via several pathways: principal metabolites generated retain significant biological activity. Endocrinology 138, 5485-5496.